S. ÇELİK Et Al. , "Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy," 10th Eurasian Hematology Oncology Congress , vol.85, İstanbul, Turkey, 2019
ÇELİK, S. Et Al. 2019. Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy. 10th Eurasian Hematology Oncology Congress , (İstanbul, Turkey).
ÇELİK, S., GÜVEN, Z. T., KAYNAR, L., ESER, B., ÇETİN, M., & ÜNAL, A., (2019). Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy . 10th Eurasian Hematology Oncology Congress, İstanbul, Turkey
ÇELİK, SERHAT Et Al. "Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy," 10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 2019
ÇELİK, SERHAT Et Al. "Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy." 10th Eurasian Hematology Oncology Congress , İstanbul, Turkey, 2019
ÇELİK, S. Et Al. (2019) . "Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy." 10th Eurasian Hematology Oncology Congress , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={SERHAT ÇELİK Et Al. }, title={Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy}, congress name={10th Eurasian Hematology Oncology Congress}, city={İstanbul}, country={Turkey}, year={2019}}